[Federal Register Volume 64, Number 219 (Monday, November 15, 1999)]
[Notices]
[Pages 61892-61893]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-29670]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Care Financing Administration
[HCFA-3027-N]


Medicare Program; Meeting of the Executive Committee of the 
Medicare Coverage Advisory Committee--December 8, 1999

AGENCY: Health Care Financing Administration (HCFA), HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a public meeting of the Executive 
Committee of the Medicare Coverage Advisory Committee (MCAC). The 
Committee provides advice and recommendations to the agency about 
clinical coverage issues. The Committee will hear reports from recent 
meetings of MCAC medical specialty panels. The Committee will also 
consider how to provide guidance to, and substantive coordination 
among, MCAC panels. For example, the Committee will consider the levels 
of evidence, types of information needed, and the nature of issues that 
will be considered by the medical specialty panels at future public 
meetings. Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. App. 2, section 10 (a)(1) and (a)(2)).

DATES:
    The Meeting: December 8, 1999, from 8 a.m. until 4 p.m., E.D.T.
    Deadline for Presentations and Comments: Submit formal 
presentations and written comments to the For Further Information 
Contact by November 18, 1999, 5 p.m., E.S.T.
    Special Accomodations: Persons attending the meeting who are 
hearing or visually impaired and have special requirements, or a 
condition that requires special assistance or accommodations, must 
notify the Executive Secretary by November 18, 1999, 5 p.m., E.D.T.

ADDRESSES:
    The Meeting: The meeting will be held at the Health Care Financing 
Administration, Main Auditorium, 7500 Security Boulevard, Baltimore, 
Maryland 21244.
    Presentations and Comments: Submit formal presentations and written 
comments to Sharon K. Lappalainen, Executive Secretary; Office of 
Clinical Standards and Quality; Health Care Financing Administration; 
7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.
    Website: You may access up-to-date information on this meeting at 
www.hcfa.gov/quality/8b.htm.

SUPPLEMENTARY INFORMATION:
    On August 13, 1999, we published a notice (64 FR 44231) to 
establish the Medicare Coverage Advisory Committee (MCAC) to provide 
advice and recommendations to us about clinical coverage issues. This 
notice announces the following public meeting of the MCAC:

Current Members of the Committee

    Thomas V. Holohan, M.A., M.D., (FACP); Leslie P. Francis, JD, 
Ph.D.; John H. Ferguson, M.D.; Robert L. Murray, Ph.D.; Alan M. Garber, 
M.D., Ph.D.; Michael D. Maves, M.D., M.B.A.; David M. Eddy, M.D., 
Ph.D.; Frank J. Papatheofanis, M.D., Ph.D.; Harold C. Sox, M.D.; Ronald 
M. Davis, M.D.; Daisy Alford-Smith, Ph.D.; Joe W. Johnson, D.C.; Robert 
H. Brook, M.D., Sc.D.; Linda A. Bergthold, Ph.D.; and Randel E. 
Richner, M.P.H.

Meeting Topic

    The Committee will hear reports from recent meetings of MCAC 
medical specialty panels. The Committee will also consider how to 
provide guidance to, and substantive coordination among, MCAC panels. 
For example, the Committee will consider the levels of evidence, types 
of information needed, and the nature of issues that will be considered 
by the medical specialty panels at future public meetings.

Procedure and Agenda

    This meeting is open to the public. The Committee will hear oral 
presentations from the public for approximately 90 minutes on the day 
of the meeting. The Committee may limit the number and duration of oral 
presentations to the time available. If you wish to make formal 
presentations, you must notify the For Further Information Contact, and 
submit the following by the Deadline for Presentations and Comments 
date listed in the Dates section of this notice: a brief statement of 
the general nature of the information you wish to present, the

[[Page 61893]]

names and addresses of proposed participants, and an estimate of the 
time required to make the presentation. We will request that you 
declare at the meeting whether or not you have any financial 
involvement with manufacturers of any items or services being discussed 
(or with their competitors).
    After public presentation, we will make a presentation to the 
Committee. After our presentation, the Committee will deliberate openly 
on the topic. Interested persons may observe the deliberations, but the 
Committee will not hear further comments during this time except at the 
request of the chairperson. At the end of the Committee deliberations, 
the Committee will allow a 30-minute open public session for any 
attendee to address issues specific to the topic. After which, the 
members will vote and the Committee will make its recommendation.

    Authority: 5 U.S.C. App. 2, section 10 (a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.774, 
Medicare--Supplementary Medical Insurance Program)

    Dated: November 5, 1999.
Jeffrey L. Kang,
Director, Office of Clinical Standards and Quality, Health Care 
Financing Administration.
[FR Doc. 99-29670 Filed 11-12-99; 8:45 am]
BILLING CODE 4120-01-P